Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / Oregon

Peptide legality · Oregon · updated 2026-09-21

Are peptides legal in Oregon?

Gray area

Peptides sit in a legal gray zone in Oregon, where FDA-approved medicines such as Wegovy® (semaglutide) are legal with a valid prescription while unapproved research peptides such as BPC-157 have no lawful compounding pathway, and the Oregon Board of Pharmacy has issued a formal position statement on GLP-1 compounding.

Legal status overview

Peptides sit in a gray zone in Oregon. The state has no peptide-specific statute, so access is governed by the federal Food, Drug, and Cosmetic Act, FDA compounding rules under sections 503A and 503B, and the Oregon Board of Pharmacy, which issued a Semaglutide Position Statement (version 2/2025) on GLP-1 compounding. FDA-approved GLP-1 receptor agonist medicines such as Ozempic® (semaglutide) and Zepbound® (tirzepatide) are legal when prescribed by a licensed clinician, while unapproved research peptides such as BPC-157 and TB-500 cannot be lawfully compounded or sold for human use. Compounded medications are not FDA-approved, are not a generic, and have not been evaluated by the FDA.

Key points

  • Oregon has no peptide-specific law; peptide access follows the federal FDA framework layered over Oregon Board of Pharmacy licensing and position statements. [2]
  • The Oregon Board of Pharmacy Semaglutide Position Statement (version 2/2025) warns that compounding or dispensing GLP-1 products in a way that fails to conform with governing law may lead to Board enforcement action. [1]
  • Oregon requires that any semaglutide base used for compounding be a pharmaceutical-grade product with a valid certificate of analysis from an FDA-registered establishment, and research-use-only material may never be used for compounding. [1]
  • BPC-157 remains in Category 2 of the FDA interim 503A bulks list, so licensed Oregon 503A compounding pharmacies may not compound it for any patient or indication. [6]
  • FDA-approved GLP-1 receptor agonist medicines are legal by prescription in Oregon when ordered by a licensed clinician subject to Oregon Medical Board prescribing rules. [3]
  • After the FDA declared the GLP-1 shortage resolved, compounding drug products that are essentially copies of approved GLP-1 medicines is generally not permitted absent a documented patient-specific clinical need. [5]
  • Growth hormone (somatropin) is an FDA-approved prescription drug, and federal law makes distributing it for non-approved uses such as anti-aging or bodybuilding a criminal offense. [7]
  • Compounded medications, including compounded semaglutide, are not FDA-approved, are not a generic, and have not been evaluated by the FDA. [5]

Compound-by-compound status

BPC-157
Restricted
Unapproved drug with no USP or NF monograph; sits in Category 2 of the FDA interim 503A bulks list, so it cannot be lawfully compounded or sold for human use in Oregon.
GLP-1 receptor agonist class (Wegovy® (semaglutide), Ozempic® (semaglutide), Zepbound® (tirzepatide), Mounjaro® (tirzepatide))
Legal
FDA-approved brands are legal by prescription; the Oregon Board of Pharmacy restricts compounded versions through its position statement, and compounded semaglutide is not FDA-approved, not a generic, and not evaluated by the FDA.
TB-500 (thymosin beta-4)
Restricted
Unapproved drug that does not appear on the FDA 503A bulks list; not lawful to compound or to sell for human use in Oregon.
Growth hormone / somatropin
Restricted
FDA-approved prescription drug limited to specific medical indications; federal law criminalizes distribution for non-approved uses such as anti-aging, athletic performance, or bodybuilding.

Frequently asked questions

Are peptides legal in Oregon?

It depends on the peptide. FDA-approved medicines such as Wegovy® (semaglutide) are legal with a valid prescription, while unapproved research peptides such as BPC-157 and TB-500 have no lawful pathway for human use. This is information, not medical or legal advice.

What does the Oregon Board of Pharmacy say about compounded semaglutide?

The Board issued a Semaglutide Position Statement (version 2/2025) warning that non-conforming compounding or dispensing may trigger enforcement, requiring pharmaceutical-grade API with a certificate of analysis from an FDA-registered establishment, and barring research-use-only material.

Can an Oregon pharmacy compound BPC-157?

No. BPC-157 is an unapproved drug in Category 2 of the FDA interim 503A bulks list, so licensed Oregon compounding pharmacies may not compound it.

Is compounded semaglutide the same as Wegovy® or Ozempic®?

No. Compounded semaglutide is not FDA-approved, is not a generic, and has not been evaluated by the FDA, unlike the approved brands Wegovy® (semaglutide) and Ozempic® (semaglutide).

Is growth hormone legal in Oregon?

Somatropin is an FDA-approved prescription drug for specific medical conditions. Federal law makes distributing it for non-approved uses such as anti-aging or bodybuilding a crime.

General information based on the sourced research above, not legal advice. For a specific situation in Oregon, consult a licensed attorney familiar with pharmaceutical law.